|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: US NEUROSURGICAL INC, 10-Q, 2000-11-14 |
Next: CLECO CORP, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCEDULE CONTAINS SUMMARY FINACIAL INFORMATION EXTRACTED FROM U.S.
NEUROSURGICAL 10Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 115,000
<SECURITIES> 0
<RECEIVABLES> 595,000
<ALLOWANCES> 150,000
<INVENTORY> 0
<CURRENT-ASSETS> 697,000
<PP&E> 8,413,000
<DEPRECIATION> 4,960,000
<TOTAL-ASSETS> 4,250,000
<CURRENT-LIABILITIES> 1,359,000
<BONDS> 1,892,000
0
0
<COMMON> 73,000
<OTHER-SE> 1,176,000
<TOTAL-LIABILITY-AND-EQUITY> 4,250,000
<SALES> 1,924,000
<TOTAL-REVENUES> 1,924,000
<CGS> 860,000
<TOTAL-COSTS> 1,827,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 235,000
<INCOME-PRETAX> (128,000)
<INCOME-TAX> (44,000)
<INCOME-CONTINUING> (84,000)
<DISCONTINUED> 109,000
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 25,000
<EPS-BASIC> 0
<EPS-DILUTED> 0
</TABLE>
|
|